Literature DB >> 11926361

Acetylation enhances the tabletting properties of starch.

Pasi Raatikainen1, Ossi Korhonen, Soili Peltonen, Petteri Parone.   

Abstract

The aim of this study was the evaluation of starch acetate (SA) powders used as tablet excipients. Deformation during powder volume reduction, strain-rate sensitivity, intrinsic elasticity of the materials, and tensile strength of the tablets were examined. Results showed that SA with the lowest degree of substitution (ds) still possessed characteristics of native starch granules. Due to dissolution in synthesis, the properties of higher ds SAs depended on precipitation and drying processes. The acetate moiety, perhaps in combination with existing hydroxyl groups, was a very effective bond-forming substituent. The formation of strong molecular bonds increased, leading to a very firm and intact tablet structure. Small changes existed in compression-induced deformation due to acetylation. Some fragmentation was induced due to the slightly harder and more irregular shape of high-substituted SA particles. The plastic flow under compression was enhanced. Acetylated material was slightly less sensitive to fast elastic recovery in-die, but somewhat more elastic out-of-die. In spite of their superior bonding, SAs under compression behaved similarly to native starches. It was concluded that deformation properties were more the consequence of the molecular chain structure properties of the starch polymer than the effect of the acetate moiety itself. In contrast, the opposite seemed to be the case with the extensive improvement in bond-forming properties.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11926361     DOI: 10.1081/ddc-120002450

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  1 in total

1.  Effects of physical properties for starch acetate powders on tableting.

Authors:  Ossi Korhonen; Seppo Pohja; Soili Peltonen; Eero Suihko; Mika Vidgren; Petteri Paronen; Jarkko Ketolainen
Journal:  AAPS PharmSciTech       Date:  2002       Impact factor: 3.246

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.